Casdin Capital, LLC Adaptive Biotechnologies Corp Transaction History

Casdin Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $6.4 Million - $14.7 Million	-1,000,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $11.1 Million - $16.2 Million	-440,000 Reduced 30.56%	1,000,000 $28.1 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $9.34 Million - $12.9 Million	290,000 Added 25.22%	1,440,000 $58.8 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $16.3 Million - $29.6 Million	436,875 Added 61.26%	1,150,000 $46.3 Million
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $2 Million - $3.87 Million	-80,000 Reduced 10.09%	713,125 $34.5 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $5.6 Million - $11.3 Million	330,000 Added 71.26%	793,125 $22 Million
Q2 2019 Aug 13, 2019	BUY	$40.3 - $48.3 $18.7 Million - $22.4 Million	463,125 New	463,125 $0

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $669M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.